An observational study on long‐term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate
Author:
Affiliation:
1. Department of Internal Medicine Yonsei University College of Medicine Seoul Korea
2. Yonsei Liver Center Severance Hospital Seoul Korea
3. Division of Gastroenterology Department of Internal Medicine Mediplex Sejong Hospital Incheon Korea
Funder
Gilead Sciences
Publisher
Wiley
Subject
Virology,Infectious Diseases,Hepatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13222
Reference33 articles.
1. Hepatitis B virus: where do we stand and what is the next step for eradication?;Komatsu H;World J Gastroenterol,2014
2. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
3. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
4. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
5. Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and safety of tenofovir disoproxil fumarate versus entecavir in the treatment of acute-on-chronic liver failure with hepatitis B: a systematic review and meta-analysis;BMC Gastroenterology;2023-11-13
2. Renal outcomes in adults with HBV, HIV and HBV/HIV coinfection after 3 years of antiviral therapy in urban Tanzania;Journal of Antimicrobial Chemotherapy;2023-11-03
3. Modification of N-hydroxycytidine yields a novel lead compound exhibiting activity against the Venezuelan equine encephalitis virus;Bioorganic & Medicinal Chemistry Letters;2023-10
4. Renal Safety of Long-term Tenofovir Disoproxil Fumarate Treatment in Patients With Chronic Hepatitis B;Open Forum Infectious Diseases;2023-08-01
5. Tenofovir alafenamide versus entecavir for treating hepatitis B virus-related acute-on-chronic liver failure: real-world study;Frontiers in Microbiology;2023-05-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3